Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study-Reference-Cited by-同舟云学术

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study

Published:2004-01 Issue:3 Volume:19 Page:115-124
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Sahin I,Serter R,Karakurt F,Demirbas B,Culha C,Taskapan C,Kosar F,Aral Y

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.tandfonline.com/doi/pdf/10.1080/09513590400004736

Reference74 articles.

1. Polycystic Ovary Syndrome

2. Obesity, lipids, cardiovascular risk, and androgen excess

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates on Molecular Targets and Epigenetic-Based Therapies for PCOS;Reproductive Sciences;2022-06-28

2. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism;Fertility and Sterility;2021-06

3. Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS;International Journal of Molecular Sciences;2020-12-15

4. Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model;American Journal of Physiology-Endocrinology and Metabolism;2019-01-01

5. Screening for insulin-independent pathways that modulate glucose homeostasis identifies androgen receptor antagonists;eLife;2018-12-06